Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Agrogeneration is a dynamic agricultural production company that operates primarily within the grain cultivation sector. Functioning as a key player in the agricultural industry, the company is focused on the production of staple crops such as wheat, barley, corn, and sunflower, contributing to the global food supply chain. Agrogeneration effectively leverages state-of-the-art farming techniques and advanced agronomy practices to enhance yield and ensure sustainable agricultural development. With a firm presence in fertile regions, Agrogeneration plays a crucial role in supporting food security and agricultural efficiency. Moreover, its operations contribute significantly to the economies in which it operates by creating job opportunities and supporting local infrastructure. By prioritizing modern agricultural methodologies and effective land management strategies, Agrogeneration underscores its commitment to ecological sustainability and operational excellence. In the financial markets, Agrogeneration holds significant importance as it offers investors exposure to the agricultural sector, which is deemed essential for portfolio diversification. The company's strategic initiatives and growth in crop production make it an important participant in meeting global agricultural demands.
€0.05
€0.00 (-0.41%)
EOD Sep 11, 2026
Margins and capital returns are both well above average: 53.56% operating margin, ROIC at 18.05%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue declined 63.7% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -€3M. The business is consuming cash, not generating it.
2.4x earnings. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€8M
▼ -63.7% YoY
Net Income (TTM)
€4M
▲ +340.5% YoY
Op. Margin
53.56%
▲ +51.4pp YoY
ROIC
18.05%
▲ +16.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€3M
▼ -12980.0% YoY
Op. Cash Flow (TTM)
-€450K
▼ -143.6% YoY
Net Debt
€13M
Cash & Equiv.
€529K
3Y CAGR: -31.8%
Continue Research
At a P/E of 2.4, Agrogeneration (ALAGR.XPAR)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Agrogeneration scores 41/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Agrogeneration scores 41 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 53.6% operating margin and a 18.0% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh ALAGR.XPAR's valuation and scores 41/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.